eHealth company Salu has formed a partnership with the AAAAI.
Salu, a B2B eHealth company building business hubs for physician specialists, has announced a partnership with the American Academy of Allergy, Asthma, and Immunology (AAAAI) to target allergists. The company’s services will be provided by the AAAAI as a benefit of membership. These will include a website builder, medical messaging and patient information.
Salu’s approach of building efficient marketplaces in key specialty areas is very different from that of many others in the eHealthcare space that are attempting to reach all physicians. But the strategy of selecting key target audiences to serve is a good one. It allows Salu to position itself as a company offering Internet tools that are specific to the specialty of the physicians that they are trying to serve, and can be used to maximize practice visibility, practice efficiency and patient care while supplying physicians with valuable resources. The company has already built vertical hubs in dermatology, reproductive medicine, cardiology, neurology and physiatry.
The company’s strategy is likely to succeed. Forming an alliance with the AAAAI can only help increase the company’s penetration in this sector. The company stands a good chance of capturing a large proportion of the allergist B2B market. If it develops similar alliances elsewhere, it could become a major force in B2B healthcare.
